The effect of citalopram on midbrain CRF receptors 1 and 2 in a primate model of stress-induced amenorrhea

Reproductive Sciences

Volumn 19, Issue 6, 2012, Pages 623-632

  Senashova, Olga ^a   Reddy, Arubala P ^c   Cameron, Judy L ^b   Bethea, Cynthia L ^c,d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

and macaques; corticotropin releasing hormone receptors; dorsal raphe; selective serotonin reuptake inhibitor; serotonin; stress

Indexed keywords

CITALOPRAM; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; ESCITALOPRAM; NORCITALOPRAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG BLOOD LEVEL; DRUG EFFECT; GENE EXPRESSION; HAPLORHINI; HYPOTHALAMIC AMENORRHEA; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; STATISTICAL SIGNIFICANCE; STRESS; TREATMENT DURATION;

AMENORRHEA; ANIMALS; CITALOPRAM; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; MACACA FASCICULARIS; MALE; RAPHE NUCLEI; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RNA, MESSENGER; SEROTONIN UPTAKE INHIBITORS; STRESS, PHYSIOLOGICAL;

EID: 84862905673     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719111430992     Document Type: Article

References (51)

1. Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients. Am J Obstet Gynecol. 1986 ; 155 (3). 531-543 (Pubitemid 16031138)
2. Giles DE, Berga SL. Cognitive and psychiatric correlates of functional hypothalamic amenorrhea: a controlled comparison. Fertil Steril. 1993 ; 60 (3). 486-492 (Pubitemid 23278806)
3. Marcus MD, Loucks TL, Berga SL. Psychological correlates of functional hypothalamic amenorrhea. Fertil Steril. 2001 ; 76 (2). 310-316 (Pubitemid 32705521)
4. Fioroni L, Fava M, Genazzani AD, Facchinetti F, Genazzani AR. Life events impact in patients with secondary amenorrhoea. J Psychosom Res. 1994 ; 38 (6). 617-622 (Pubitemid 24256720)
5. Laughlin GA, Dominguez CE, Yen SS. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab. 1998 ; 83 (1). 25-32 (Pubitemid 28498306)
6. Berga SL, Marcus MD, Loucks TL, Hlastala S, Ringham R, Krohn MA. Recovery of ovarian activity in women with functional hypothalamic amenorrhea who were treated with cognitive behavior therapy. Fertil Steril. 2003 ; 80 ((4 )). 976-981 (Pubitemid 37230035)
7. Tschugguel W, Berga SL. Treatment of functional hypothalamic amenorrhea with hypnotherapy. Fertil Steril. 2003 ; 80 ((4 )). 982-985 (Pubitemid 37230036)
8. Bethea CL, Centeno ML, Cameron JL. Neurobiology of stress-induced reproductive dysfunction in female macaques. Mol Neurobiol. 2008 ; 38 (3). 199-230
9. Linthorst AC.. Interactions between corticotropin-releasing hormone and serotonin: implications for the aetiology and treatment of anxiety disorders. Handb Exp Pharmacol. 2005 ; (169). 181-204
10. Luiten PG, ter Horst GJ, Karst H, Steffens AB. The course of paraventricular hypothalamic efferents to autonomic structures in medulla and spinal cord. Brain Res. 1985 ; 329: 374-8 (Pubitemid 15141320)
11. Ruggiero DA, Underwood MD, Rice PM, Mann JJ, Arango V. Corticotropic-releasing hormone and serotonin interact in the human brainstem: behavioral implications. Neuroscience. 1999 ; 91 (4). 1343-1354 (Pubitemid 29234263)
12. Dautzenberg FM, Hauger RL. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci. 2002 ; 23 (2). 71-77 (Pubitemid 34119328)
13. Vaughan J, Donaldson C, Bittencourt J, et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature. 1995 ; 378 (6554). 287-292
14. Lukkes JL, Forster GL, Renner KJ, Summers CH. Corticotropin-releasing factor 1 and 2 receptors in the dorsal raphe differentially affect serotonin release in the nucleus accumbens. Eur J Pharmacol. 2008 ; 578 (2-3). 185-193 (Pubitemid 350309588)
15. Valdez GR, Inoue K, Koob GF, Rivier J, Vale W, Zorrilla EP. Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide. Brain Res. 2002 ; 943 (1). 142-150 (Pubitemid 34671182)
16. Azmitia EC, Gannon PJ. The primate serotonergic system: a review of human and animal studies and a report on Macaca fascicularis. Adv Neurol. 1986 ; 43: 407-468
17. Jacobs BL, Azmitia EC. Structure and function of the brain serotonin system. Physiolog Rev. 1992 ; 72 (1). 165-231
18. Bethea CL, Centeno ML. Ovarian steroid treatment decreases corticotropin-releasing hormone (CRH) mRNA and protein in the hypothalamic paraventricular nucleus of ovariectomized monkeys. Neuropsychopharmacology. 2008 ; 33 (3). 546-556
19. Centeno ML, Sanchez RL, Reddy AP, Cameron JL, Bethea CL. Corticotropin-releasing hormone and pro-opiomelanocortin gene expression in female monkeys with differences in sensitivity to stress. Neuroendocrinology. 2007 ; 86 (4). 277-288 (Pubitemid 350136510)
20. Fuller RW. The involvement of serotonin in regulation of pituitary-adrenocortical function. Front Neuroendocrinol. 1992 ; 13 (3). 250-270
21. Michelsen KA, Schmitz C, Steinbusch HW. The dorsal raphe nucleus-from silver stainings to a role in depression. Brain Res Rev. 2007 ; 55 (2). 329-242
22. Clark MS, Kaiyala KJ. Role of corticotropin-releasing factor family peptides and receptors in stress-related psychiatric disorders. Semin Clin Neuropsychiatry. 2003 ; 8 (2). 119-136 (Pubitemid 36828243)
23. Reul JM, Holsboer F. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr Opin Pharmacol. 2002 ; 2 (1). 23-33
24. Maier SF, Watkins LR. Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neurosci Biobehav Rev. 2005 ; 29 (4-5). 829-841 (Pubitemid 40762600)
25. Vaswani M, Linda FK, Ramesh S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 2003 ; 27 (1). 85-102 (Pubitemid 36131110)
26. Li XF, Bowe JE, Kinsey-Jones JS, Brain SD, Lightman SL, O'Byrne KT. Differential role of corticotrophin-releasing factor receptor types 1 and 2 in stress-induced suppression of pulsatile luteinising hormone secretion in the female rat. J Neuroendocrinol. 2006 ; 18 (8). 602-610
27. Rivier C, Rivier J, Vale W. Stress-induced inhibition of reproductive functions: role of endogenous corticotropin-releasing factor. Science. 1986 ; 231 (4738). 607-609 (Pubitemid 16088944)
28. Bethea CL, Pau FK, Fox S, Hess DL, Berga SL, Cameron JL. Sensitivity to stress-induced reproductive dysfunction linked to activity of the serotonin system. Fertil Steril. 2005 ; 83 (1). 148-155 (Pubitemid 40094794)
29. Lima FB, Centeno ML, Costa ME, Reddy AP, Cameron JL, Bethea CL. Stress sensitive female macaques have decreased fifth Ewing variant (Fev) and serotonin-related gene expression that is not reversed by citalopram. Neuroscience. 2009 ; 164 (2). 676-691
30. Bethea CL, Streicher JM, Mirkes SJ, Sanchez RL, Reddy AP, Cameron JL. Serotonin-related gene expression in female monkeys with individual sensitivity to stress. Neuroscience. 2005 ; 132 (1). 151-166 (Pubitemid 40380722)
31. Weissheimer KV, Herod SM, Cameron JL, Bethea CL. Interactions of corticotropin-releasing factor, urocortin and citalopram in a primate model of stress-induced amenorhea. Neuroendocrinology. 2010 ; 92 (4). 224-234
32. Cameron JL, Bytheway JA, Guay S, et al Treatment with a serotonin reuptake inhibitor increases reproductive hormone secretion in stress sensitive monkeys.
33. Berg-von der Emde K, Dees WL, Hiney JK, et al. Neurotrophins and the neuroendocrine brain: different neurotrophins sustain anatomically and functionally segregated subsets of hypothalamic dopaminergic neurons. J Neurosci. 1995 ; 15 (6). 4223-4237
34. Berga SL, Loucks TL. Use of cognitive behavior therapy for functional hypothalamic amenorrhea. Ann N Y Acad Sci. 2006 ; 1092: 114-129 (Pubitemid 47092331)
35. Reame NE, Sauder SE, Case GD, Kelch RP, Marshall JC. Pulsatile gonadotropin secretion in women with hypothalamic amenorrhea: evidence that reduced frequency of gonadotropin-releasing hormone secretion is the mechanism of persistent anovulation. J Clin Endocrinol Metab. 1985 ; 61 (5). 851-858 (Pubitemid 16218480)
36. Berga SL, Loucks TL. The diagnosis and treatment of stress-induced anovulation. Minerva Ginecol. 2005 ; 57 (1). 45-54 (Pubitemid 43942483)
37. Ali MK, Lam RW. Comparative efficacy of escitalopram in the treatment of major depressive disorder. Neuropsychiatr Dis Treat. 2011 ; 7: 39-49
38. Portella MJ, de Diego-Adelino J, Ballesteros J, et al. Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? a randomized clinical trial and a meta-analysis of pindolol in nonresistant depression. J Clin Psychiatry. 2010 ; 72 (7). 962-969
39. Entsuah AR, Huang H, Thase ME. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo. J Clin Psychiatry. 2001 ; 62 (11). 869-877 (Pubitemid 33131173)
40. Kirby LG, Rice KC, Valentino RJ. Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology. 2000 ; 22 (2). 148-162 (Pubitemid 30016017)
41. Pernar L, Curtis AL, Vale WW, Rivier JE, Valentino RJ. Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions. J Neurosci. 2004 ; 24 (6). 1305-1311 (Pubitemid 38222980)
42. Müller MB, Zimmermann S, Sillaber I, et al. Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat Neurosci. 2003 ; 6 ((10 )). 1100-1107 (Pubitemid 37186203)
43. Bailey JE, Papadopoulos A, Diaper A, et al. Preliminary evidence of anxiolytic effects of the CRF1 receptor antagonist R317573 in the 7.5% CO2 proof-of-concept experimental model of human anxiety. J Psychopharmacol. 2011 ; 25 (9). 1199-1206
44. Licinio J, O'Kirwan F, Irizarry K, et al. Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans. Mol Psychiatry. 2004 ; 9 (12). 1075-1082 (Pubitemid 40065452)
45. Herod SM, Bytheway J, Dolney R, Cameron JL Female monkeys who are sensitive to stress-induced reproductive dysfunction also show increases in certain forms of anxious behavior. Atlanta, GA: ; 2006 :
46. Kirby LG, Freeman-Daniels E, Lemos JC, et al. Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neurons. J Neurosci. 2008 ; 28 (48). 12927-12937
47. Day HE, Greenwood BN, Hammack SE, et al. Differential expression of 5HT-1A, alpha 1b adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus. J Comp Neurol. 2004 ; 474 (3). 364-378 (Pubitemid 38720432)
48. Herod S, Cameron JL Female monkeys sensitive to stress-induced reproductive dysfunction have low central drive to the reproductive axis in nonstressed conditions. Toronto, Canada: ; 2007 :
49. Herod SM, Pohl CR, Cameron JL. Treatment with a CRH-R1 antagonist prevents stress-induced suppression of the central neural drive to the reproductive axis in female macaques. Am J Physiol Endocrinol Metab. 2011 ; 300 (1). E19 - E27
50. Berga SL, Girton LG. The psychoneuroendocrinology of functional hypothalamic amenorrhea. Psychiatr Clin North Am. 1989 ; 12 (1). 105-116
51. Bethea CL, Lima FB, Centeno ML, et al. Effects of citalopram on serotonin and CRF systems in the midbrain of primates with differences in stress sensitivity. J Chem Neuroanat. 2011 ; 41 (4). 200-218